Bladder cancer treatment receives FDA approval in Saudi

u/AceTrentura · Reddit — r/wallstreetbets · January 14, 2026 at 21:10 · ⬆ 4 pts · 💬 10 comments  | View on Reddit ↗
AI Summary

Original Reddit post

Author is long IBRX, citing FDA approval of its bladder cancer treatment in Saudi Arabia and prior large price moves on news.

IBRX — LONG The author has held IBRX for a long time, citing strong research and development and a capable CEO. The catalyst is FDA approval of its bladder cancer treatment in Saudi Arabia, with major price moves in the last week. The author notes the stock is very news-dependent, having previously run from about $7 to $45 quickly.

Bladder cancer treatment receives FDA approval in Saudi

Score 4
Comments 10
▶ Full Post Text
Ideas
u/AceTrentura Reddit r/wallstreetbets
IBRX long on Saudi bladder cancer approval
The author has held IBRX for a long time, citing strong research and development and a capable CEO. The catalyst is FDA approval of its bladder cancer treatment in Saudi Arabia, with major price moves in the last week. The author notes the stock is very news-dependent, having previously run from about $7 to $45 quickly.
IBRX MED
More from Reddit — r/wallstreetbets
PLTR gains
Jan 14, 21:09
What Are Your Moves Tomorrow, January 15, 2026
Jan 14, 20:57
To whoever bought this. You’re welcome
Jan 14, 20:41
My 401k feels like a scam (and I’m tired of pretending it isn’t)
Jan 14, 20:37
The sign we’ve been waiting for.
Jan 14, 20:32

This Reddit post, published January 14, 2026, features u/AceTrentura discussing IBRX. 1 trade idea extracted by AI with direction and confidence scoring.

Speakers: u/AceTrentura  · Tickers: IBRX